Collectively, these findings illustrate the complex processes that contribute to LAM fibrosis and establish PGR signaling as a driver of hernia development as well as a potential target for pharmacologic management of inguinal hernia. This evidence concerns the gene PGR and lymphangioleiomyomatosis.